FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/095019 [Registered on: 18/09/2025] Trial Registered Prospectively
Last Modified On: 16/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A Study in Adult Women Undergoing Breast Cancer Surgery to Compare Pain Relief from Erector Spinae Plane Block Using Ropivacaine with Dexmedetomidine Versus Ropivacaine Alone 
Scientific Title of Study   EFFICACY OF ERECTOR SPINAE PLANE BLOCK USING ROPIVACAINE-DEXMEDETOMIDINE COMBINATION VERSUS ROPIVACAINE ALONE IN ADULT FEMALES UNDERGOING BREAST ONCOSURGERY –A RANDOMIZED CONTROLLED TRIAL 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anjali Gera 
Designation  Senior consultant 
Affiliation  Sir Ganga Ram Hospital, New Delhi  
Address  Institute of Anaesthesiology, Pain and Perioperative Medicine,Sir Ganga Ram hospital, New Delhi-110060, INDIA
Institute of Anaesthesiology, Pain and Perioperative Medicine, Sir Ganga Ram hospital, New Delhi-110060, INDIA
Central
DELHI
110060
India 
Phone  9811571080  
Fax    
Email  anjali_chawla@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anjali Gera 
Designation  Senior consultant 
Affiliation  Sir Ganga Ram Hospital, New Delhi  
Address  Institute of Anaesthesiology, Pain and Perioperative Medicine,Sir Ganga Ram hospital, New Delhi-110060, INDIA
Institute of Anaesthesiology, Pain and Perioperative Medicine, Sir Ganga Ram hospital, New Delhi-110060, INDIA
Central
DELHI
110060
India 
Phone  9811571080  
Fax    
Email  anjali_chawla@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Gunjeet kaur 
Designation  Post diploma DNB trainee  
Affiliation  Sir Ganga Ram Hospital, New Delhi  
Address  Institute of Anaesthesiology, Pain and Perioperative Medicine, Sir Ganga Ram Hospital, New Delhi-110060, INDIA
Institute of Anaesthesiology, Pain and Perioperative Medicine, Sir Ganga Ram hospital, New Delhi-110060, INDIA
Central
DELHI
110060
India 
Phone  8054181819  
Fax    
Email  gunjeetkaur983@gmail.com  
 
Source of Monetary or Material Support  
Sir Ganga Ram Hospital, New Delhi 
 
Primary Sponsor  
Name  Sir Ganga Ram Hospital, New Delhi 
Address  Institute of Anaesthesiology, Pain and Perioperative Medicine,3rd floor Block E, SGRH, Old Rajinder Nagar, New Delhi-110060, INDIA  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anjali Gera  Sir Ganga Ram Hospital  OT-4,3rd Floor Block E, Sir Ganga Ram Hospital, New Delhi, 110060, INDIA
Central
DELHI 
9811571080

anjali_chawla@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics Committee, Sir Ganga Ram Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  ERECTOR SPINAE PLANE BLOCK USING ROPIVACAINE ALONE  ERECTOR SPINAE PLANE BLOCK WILL BE GIVEN UNDER ULTRASOUND GUIDANCE BEFORE EX USING ROPIVACAINE ALONE 
Intervention  ERECTOR SPINAE PLANE BLOCK USING ROPIVACAINE-DEXMEDETOMIDINE COMBINATION  ERECTOR SPINAE PLANE BLOCK WILL BE GIVEN UNDER ULTRASOUND GUIDANCE BEFORE EXTUBATION OF THE PATIENT USING ROPIVACAINE-DEXMEDETOMIDINE COMBINATION 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Female 
Details  1. 18-65 years
2. ASA physical status I, II, III 
 
ExclusionCriteria 
Details  1. Anomalies of vertebral column
2. Any lesion obscuring Sono anatomy of injection site
3. History of allergy to study drugs
4. Patient not consenting to participate in the study 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Post-operative pain assessed using VAS score   Postoperatively at 30 mins, 2 hr, 4 hr, 6 hr,12 hr,24 hr 
 
Secondary Outcome  
Outcome  TimePoints 
1. Total rescue analgesics dose requirements
2. Post-operative nausea and vomiting
3. Patient satisfaction
4. Post-operative sedation
5. Hemodynamic instability 
30 minutes, 2 hours, 4 hours, 6 hours, 12 hours and 24 hours 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Breast cancer is the most commonly diagnosed cancer in women in India as per the National Cancer Registry Programme (NCRP) 2020 report by the Indian Council of Medical Research making Modified Radical Mastectomy (MRM) and flap reconstruction, the most commonly performed surgeriesMRM is usually done under general anesthesia (GA) using intravenous opioids but the incidence of moderate to severe postoperative pain after mastectomy under GA is high. ESP (Erector Spinae Plane) block in breast surgeries has been found to effectively reduce post operative pain and opioid consumption. Bupivacaine, a long-acting amide local anaesthetic, has been widely utilized in ESP blocks, demonstrating consistently favourable outcomes in terms of pain control and opioid-sparing effects. Ropivacaine, a long-acting amide local anaesthetic is an alternative to Bupivacaine and has superior cardiovascular safety profile with comparable analgesic efficacy. Structurally similar to Bupivacaine but less lipophilic, Ropivacaine has a lower propensity for central nervous system and cardiac toxicity, making it particularly suitable for patients with cardiovascular risk factors. Duration of analgesia with Ropivacaine alone is around 10-12 hours, Dexmedetomidine acts synergistically with LA (Local Anaesthetics) by prolonging the duration of sensory blockade, reducing nociceptive transmission, and attenuating central sensitization. Its analgesic properties contribute to reduced opioid requirements and improved patient comfort without significant respiratory depression.   
Close